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stabilityAL amyloidosis is characterized by the pathologic deposition as ﬁbrils of monoclonal light chains (i.e., Bence
Jones proteins [BJPs]) in particular organs and tissues. This phenomenon has been attributed to the presence
in amyloidogenic proteins of particular amino acids that cause these molecules to become unstable, as well
as post-translational modiﬁcations and, in regard to the latter, we have investigated the effect of biotiny-
lation of lysyl residues on cell binding. We utilized an experimental system designed to test if BJPs obtained
from patients with AL amyloidosis or, as a control, multiple myeloma (MM), bound human ﬁbroblasts
and renal epithelial cells. As documented by ﬂuorescence microscopy and ELISA, the amyloidogenic BJPs,
as compared with MM components, bound preferentially and this reactivity increased signiﬁcantly after
chemical modiﬁcation of their lysyl residues with sulfo-NHS-biotin. Further, based on tryptophan ﬂuores-
cence and circular dichroism data, it was apparent that their conformation was altered, which we hypo-
thesize exposed a binding site not accessible on the native protein. The results of our studies indicate that
post-translational structural modiﬁcations of pathologic light chains can enhance their capacity for cellular
interaction and thus may contribute to the pathogenesis of AL amyloidosis and multiple myeloma.s Division, Oak Ridge National
SA.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Plasma cell dyscrasias, e.g., multiplemyeloma, light chain deposition
disease, and AL amyloidosis, are associated with the overexpression of
monoclonal light chains (LCs), i.e., Bence Jones proteins (BJPs), that
deposit, respectively, as renal tubular casts, membrane deposits, and
amyloid ﬁbrils [1,2]. These sequelae have been attributed to primary
structural differences in the pathologic protein that induce formation of
amorphous, punctuate, or ﬁbrillar tissue aggregates [3,4]. In the case of
AL amyloidosis, other factors such as post-translational modiﬁcation,
including glycosylation and cysteinylation, have been implicated in LC
ﬁbrillogenesis [5–8]. Further, lipid peroxidation and advanced glycation
end products have been immunolocalized with AL deposits suggesting
these non-enzymatic alterations may be involved in this process [9].
Although it has been shown that adduction of side-chain amino acids
can result in aggregation of certain amyloidogenic precursor proteins(i.e.,α-synuclein and Aβ peptides), heretofore, this effect on LCs has not
been studied [10–12].
Surface contact is yet another factor thought to be important in LC
ﬁbrillogenesis, based on the fact that amyloid localizes preferentially
along the basement membranes of endothelial and epithelial cells and
additionally, the presence of raft lipids in isolates of systemic amyloid
deposits [13,14]. In this regard, interaction of LCs with artiﬁcial
surfaces, such as electronegatively charged mica or membrane lipids,
has been shown to promote ﬁbril formation [15,16] and we have
evidenced that their adhesion to plastic surfaces results in a
conformational change that renders these molecules reactive with
an anti-ﬁbril speciﬁc mAb [17]. Notably, these phenomena could lead
to an increase in the local concentration of denatured LCs at cell
surfaces, promoting protein aggregation and ﬁbril formation and then
recruitment of unmodiﬁed proteins into the pathologic deposits.
In this study, we have investigated the effect of lysine modiﬁcation
of monoclonal LC primary amines (through biotinylation) to evaluate
the stability of AL amyloid- versus non-amyloid-associated BJPs and to
test their capacities to interact with human ﬁbroblast and epithelial
cells. We have found that this alteration affected the AL components
predominantly, resulting in reduced stability and enhanced cellular
binding. On this basis, we suggest that these events can contribute to
the pathogenesis of AL amyloidosis.
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2.1. Proteins and chemical modiﬁcation
λ-type BJPs were isolated from the urine of 2 AL patients in whom
there was extensive organ involvement (FRE, IRHE) and 2 patients
with multiple myeloma (MM) but no evidence of amyloid at post-
mortem examination (JRHE and HUD). JRHE had renal tubular cast
nephropathy. The proteins were reconstituted in phosphate buffered
saline (PBS), pH 7.4, at a concentration of 1–2 mg/ml and were incu-
bated in the dark with a 6 to 20-fold molar excess of sulfo-NHS-biotin
(Pierce, Rockford, IL) for 2 h at room temperature; free biotin was
removed by size exclusion gel ﬁltration using a PD-10 desalting
column (Amersham Biosciences, Uppsala, Sweden). Protein concen-
trations were determined using a micro BCA assay kit (Pierce).
2.2. Mass spectrometry
Solutions of native and modiﬁed BJPs (0.1–1 mg/ml) were loaded
into a 20-μl injection loop of an Applied Biosystems (Foster City, CA)
173 capillary HPLC and chromatographed over 90 min using a reverse
phase Aquapore 300 C8 (150×0.5 mm) columnwith a gradient of 15–
70% acetonitrile modiﬁed with 0.02% triﬂuoroacetic acid; the eluent
was directed into the ion-spray of a PE-Sciex (Applied Biosystems)
type 150 EX single quadrupole mass spectrometer and masses
were determined using the Biomultiview software provided by the
manufacturer.
2.3. Immunoﬁxation electrophoresis
Immunoﬁxation electrophoresis was performed according to the
manufacturer's instructions (Paragon, Beckman Coulter, Ireland). In
brief, 3–6 μl of 0.4 mg/ml solutions of native and biotinylated BJPs
were applied to themembrane and immunostainedwith the anti-λ LC
antibody. The reaction was visualized with Paragon blue stain.
2.4. Cells and culture conditions.
Human foreskin ﬁbroblasts were obtained from the American Type
Tissue Culture Collection and cultured in EMEM containing 2 mM L-
glutamine, 1.5 g/L sodium bicarbonate, 1.0 mM sodium pyruvate, and
0.1 mM non-essential amino acids, supplemented with 10% FCS and
penicillin (50 U/ml)/ streptomycin (50 μg/ml). Experiments were
performed with cells having undergone b41 population doublings.
Human renal epithelial cells (HRECs) were supplied by Lonza
(Walkersville, MD) and were cultured in basal REC media, supple-
mented with RE growth medium Bulletkit® that contained hydro-
cortisone, hEGF, insulin, triiodothyronine, transferrin, gentamicin,
amphotericin-B, and 0.5% FBS. The cells used were from passages 4 to
6 and were negative for mycoplasma (Lonza Mycoalert kit).
2.5. Microscopic analysis of LC-cell interaction
Cells were grown to conﬂuence on sterile glass coverslips placed in
6-well tissue culture dishes and incubated under 5% CO2 for 3 h at
37 °C with and without native or biotinylated BJPs (100 μg/0.5 ml).
The cells were washed gently 3 times with growth media to remove
unbound BJP. Native light chains were further incubated with a
biotinylated anti-λ (Fλ-G9) antibody for 1 h at 37 °C and washed to
remove unbound antibody [18]. To stain F-actin, Alexa Fluor®-488
phalloidin (Invitrogen, Molecular Probes, Eugene, OR) in cytoﬁx/
cytoperm® reagent (BD Biosciences, Pharmingen, San Diego CA) was
added to a ﬁnal concentration of 30 μg/ml. The cells were incubated
for 20 min at 23 °C on a rocking platform, and then for 15 min in a
1:10 dilution of Perm-wash buffer (BD Biosciences, Pharmingen, San
Diego CA). Nuclei were stained for 30 min at 37 °C with Hoechst33342 trihydrochloride-trihydrate/PBS (Invitrogen). Biotinylated LCs
were visualized by addition of streptavidin-Alexa Fluor®-594 (Invi-
trogen) for 1 h at 23 °C. After the ﬁnal PBS and water washes, cells
were coverslipped using ﬂuorescent aqueous mounting medium
(Dakocytomation, Carpinteria, CA) and examined within 72 h with an
epiﬂuorescent microscope. Images were recorded with a 3-chip color
CCD camera (Diagnostic Spot RT 2.2.0).
2.6. Quantitative analysis of LC-cell interaction
Cells were grown to conﬂuence in 96-well plates and incubated
under 5% CO2 for 3 h at 37 °C, with and without native or biotinylated
BJPs (50–200 μg/ml in 100 μl volumes). Each well was washed
repeatedly with 200 μl of growth media to remove unbound protein
and bound BJP was detected using an HRP-labeled anti-human λ LC
antibody (Biosource, Camarillo, CA). The wells were washed 3 times
and the HRP signal detected using an ABTS solution (KPL, Gaithers-
burg, MD); the presence of cells was conﬁrmed by microscopy.
Absorbance was measured at 405 nm using a BIO-TEK Synergy HT
multi-detection microplate reader. To control for non-speciﬁc binding
of the secondary antibody, absorbance values for wells containing
cells, but no BJP, were subtracted from those of test wells. All assays
were done in triplicate.
2.7. Thermal denaturation of LCs
BJPs (25 μg/ml) were suspended in 2.5 ml PBS in a 3-ml quartz
cuvette with stirring. A temperature probewas inserted and the sample
heated from 22 to 65 °C at a rate of 2 °C per min. Tryptophan (Trp)
ﬂuorescence was measured using an SLM Thermospectronic Aminco
Bowman (Series II) spectroﬂuorometer (excitation, 290 nm; emission,
410 nm). Slit widths of 4 and 8 nm were used and the photomultiplier
tube voltage was set at 850 V.
2.8. Calculation of free energy of unfolding
The free energy of unfolding for each protein was determined
using thermal denaturation data as described previously [19]. A
correction was made for the contribution of quenched ﬂuorescent Trp
residues according to the following transformation:
ycorr= y–cð Þ–mx
where y, m, and c represent, respectively, the original value, the gradient,
and the intercept at x=0, of the linear quenching of the foldedmolecule.
The Tm and ΔHm were calculated by nonlinear least-squares analysis of
the corrected thermal denaturation data using an equation adapted from
Eftink [20]. The value of ΔG at room temperature (ΔG25 °C) was
determined as follows:
ΔG Tð Þ=ΔHm 1−T = Tmð Þ−ΔCp Tm−Tð Þ+Tln T = Tmð Þ½ 
where T=298 °K and ΔCp represented the change in heat capacity
associated with unfolding, as calculated theoretically according to the
method of Milardi [21]. All parameters were determined using the
nonlinear, least-squares ﬁtting program ULTRAFIT (Biosoft, UK).
2.9. Fluorescence emission spectra of modiﬁed and native LCs
Sample (25 μg/ml) volumesof 0.5 or 2.5 ml in PBS, pH7.4,wereplaced
in quartz cuvettes, stirred, and ﬂuorescence measured (excitation, 280
and 295 nm; slit width, 4 nm and emission, 300–450 nm; slit width,
8 nm) at 37 °C. Data from 3 repetitionswere collected using a scan rate of
1 nm per sec and then averaged.
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CD spectroscopy measurements were performed with a Jasco
810 spectropolarimeter equipped with a Peltier temperature control
unit. Proteins were dissolved in 25 mM Na-phosphate buffer, pH 7.0,
at concentrations between 0.8 and 1.0 mg/ml. The spectra were
recorded in a 0.1 cm path-length cuvette (190–350 nm) at 37 °C and
the data expressed as mean residue ellipticity ([θ]). Thermal dena-
turation experiments were performed in a 0.1 cm path-length cuvetteFig. 1. Immunocytochemical demonstration of the binding LCs to human foreskin ﬁbroblasts.
IRHE (Panels b and f) and myeloma-associated BJPs HUD (Panels c and g) and JRHE (Panels d
nuclei, respectively (magniﬁcation ×400).and spectra recorded in the range of 195–350 nm between 25 and
80 °C at 2 °C intervals at a rate of 2 °C/min. Single wavelength kinetics
were reported at 205 nm.
2.11. Statistical analysis
Unpaired ANOVA, followed by a Tukeymultiple comparison post test,
was used (GraphPad Prism version 4.00 for Windows, GraphPad
Software, San Diego California USA, www.graphpad.com).Cells were exposed to native or biotinylated AL-associated BJPs FRE (Panels a and e) and
and h). Red, green and blue ﬂuorescence indicates the presence of LCs, F-actin, and cell
Fig. 2. Comparison of native and biotinylated LCs interaction with human renal epithelial
cells. Amyloid-associatedBJPs: FRE(a) and IRHE (b) andmyeloma-associatedBJPsHUD(c)
and JRHE (d). Native (□) and biotinylated (■). The data represent mean±SEM, (n=3).
**pb0.01, ***pb0.001.
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Sequence alignment of the 4 LCswas performed using the CLUSTAL
2.0 Multiple alignment software [22].
3. Results
3.1. Biotin–LC binding
Quantitative assessment of the number of biotin molecules that
bound to the 4 λ-type BJPs was determined using liquid chromatog-
raphy–mass spectrometry (LC-MS) (supplemental data Fig. 1) and
provided information thatwas correlatedwith their pathogenicity and
interaction with cultured cells. Electrophoretic analysis (SDS-PAGE)
indicated that all had the expected Mr of a disulphide-linked covalent
LC dimer (Supplemental data Fig. 2).
3.2. Modiﬁcation of LC lysines alters cellular interactions
The 2 amyloidogenic BJPs (FRE and IRHE) preferentially adhered
to cultured human cells after attachment of biotin to their lysyl
residues. As shown in Fig. 1, they interacted more strongly (as
evidenced by the red ﬂuorescence) with human foreskin ﬁbroblasts
than did the biotinylated non-amyloid counterparts (HUD and JRHE).
Notably, there was little or no binding by any of the 4 in their native
state. These data were conﬁrmed by a quantitative immunoassay
where signiﬁcant increases were seen, at all concentrations tested, in
the binding of biotinylated versus native FRE and IRHE (pb0.001)
(Fig. 2a and b). This effect also was observed in the case of JRHEFig. 3. Thermal denaturation of native and biotinylated LCs. (a) Number of biotin
molecules on amyloid-associated BJPs, FRE (Δ), and IRHE (▼) and myeloma-associated
BJPs, HUD (●), JRHE (□). (b) Change in CD signal at 205 nm for native (■) and bio-
tinylated FRE (Δ) containing ~10 biotins per BJP.
Table 1
Thermodynamic parameters of native and biotinylated LCs.
Parameter FRE IRHE HUD JRHE
Native Biotina Native Biotinb Native Biotinc Native Biotind
Tm (K) 327.03 320.29 324.30 321.30 328.30 323.30 329.22 324.15
ΔHm (kcal/mol) 59.37 39.02 45.44 47.12 67.81 56.95 59.14 78.62
CpTotal (kcal/kmol) 3.50 3.50 3.44 3.44 3.40 3.40 3.55 3.55
ΔG(T) (kcal/mol) 5.21 2.68 3.64 3.37 6.19 4.40 5.55 6.27
a, b, c, d: 12, 8, 12, 10, biotins/dimer.
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(Fig. 2c). Notably, lysyl modiﬁcation of non-amyloidogenic HUD did
not signiﬁcantly change its interaction with HRECs (Fig. 2d).
In their native state the 2 AL proteins FRE and IRHE adhered to
HRECs signiﬁcantly more than native JRHE at 100 μg/ml (FRE vs.
JRHE pb0.001 and JRHE vs. IRHE pb0.01) and 200 μg/ml (pb0.001
comparing both AL proteins to JRHE). Native HUD exhibited increased
adhesion to HREC relative to native JRHE at all concentrations tested
(pb0.05 at 50 μg/ml and pb0.001 at 100 and 200 μg/ml). However,
HUD did not differ in its basal adhesion to HRECs when compared
with the 2 AL-LCs.Fig. 4. Electrophoretic mobility of native and biotinylated LCs. Immunoﬁxation
electrophoresis of BJPs (biotinylated/native): IRHE (a/b), FRE (c/d), JRHE (e/f), and HUD
(g/h). Proteins were immunostained with an anti-λ-chain antibody.3.3. Effect of lysine modiﬁcation on LC thermodynamic stability
The change in Trp ﬂuorescence intensity of native and biotinylated
BJPs, resulting from increasing the temperature from 22 to 60 °C, was
monitored and the midpoint transitional temperature (Tm) deter-
mined. In the case of native FRE, this value was 53.7 °C, which
decreased to 47 °C after addition of 12 biotins per dimer. Similarly,
native HUD and JRHE had Tm values of 55 °C and 55.6 °C, respectively,
which went down to 48.8 °C (HUD) and 49 °C (JRHE) after maximal
biotinylation (Fig. 3a). In the case of IRHE, the Tm was 51.5 °C, but
dropped to 48.5 °C after addition of 8 biotins to the dimer. Comparable
results were obtained by CD analysis of thermally denatured FRE;
namely, there was reduced stability after lysinemodiﬁcation (Fig. 3b).
Calculation of the Gibbs Free Energy (ΔG) for all 4 BJPs (Table 1)
revealed that this value changed dramatically after biotinylation of
FRE and HUD (2.68 and 4.4, respectively) as compared to the native
proteins (5.21 and 6.19, respectively). The amyloidogenic BJP IRHE
was already quite unstable with a ΔG of 3.64, which fell to 3.37 after
lysine modiﬁcation, while the value for the MM-associated BJP JRHE
increased from 5.55 to 6.27.
3.4. Effect of lysine modiﬁcation on LC charge, secondary structure, and
ﬂuorescence spectra
As found electrophoretically, the addition of biotin to the 4 BJPs
effectively increased their pI, rendering them more electronegative
(Fig. 4). Native IRHE, FRE, and JRHE had similar migration patterns,
while unmodiﬁed HUD was slightly more anionic.
The Trp emission spectra (excitation, 295 nm) of the BJPs at 37 °C
decreased after biotin labeling (Fig. 5). This effect was greater for the
IRHE and HUD proteins, as compared to FRE and JRHE. Similar results
were observed when Trp/Tyr ﬂuorescence was measured (excitation,
280 nm).
The CD spectra of native and biotinylated proteins revealed that
they were composed primarily of β-sheets with minimal amounts of
α-helix present (Fig. 6). The spectra of both forms were similar,
evidencing that their shape was not altered by lysine modiﬁcation.
However, biotinylation of the LCs did result in an increase in the
negative maxima at 217 nm, indicative of enhanced β-sheet forma-
tion [23]. This alteration was most apparent for FRE and JRHE.3.5. Multiple alignment comparison of LC sequences
The sequence alignment data indicate that there is a signiﬁcant
amount of homology between the 4 λ LCs but particularly between
the 3 λ3a LCs (Table 2). All of the lysyl residues are located within the
framework regions (FRs) of the LC variable domains except Lys29
in the complementarity determining region (CDR) 1 of FRE (Fig. 7).
Neither IRHE nor HUD contains a Lys in FR1 whereas both FRE and
JRHE have a Lys at position 15 in this region. HUD and IRHE both
contain one Lys in FR2. This is the only lysyl residue within the
variable region of IRHE. HUD however has a second Lys within FR3.
None of the λ3a LCs has a Lys within this region. The position of the
Lysyl residues within the constant domains is similar for all LCs with
the exception of an extra Lys192 in HUD and Lys190 in JRHE (Fig. 7).
4. Discussion/conclusion
Lysine modiﬁcation has been reported to alter protein conforma-
tion and function and has been implicated in the conversion of amy-
loidogenic precursor proteins, i.e., β2-microglobulin, α-synuclein and
Aβ peptide, into ﬁbrils [10–12,24]. Similarly, glycation of albumin via
lysyl side chain modiﬁcations can lead to the formation of ﬁbrils or
amorphous aggregates [25]. The effects of lysyl adduction on
pathogenic LCs have not previously been investigated. Although
biotinylation is unlikely to occur in vivo the effects observed in this
study may be mirrored by natural modiﬁcations such as glycation or
lipoxidation [26]. Our model system has provided evidence that
biotinylation of 2 amyloid-forming LCs (FRE and IRHE) and 2 non-
amyloid forming LCs (JRHE and HUD) resulted in altered stability and
conformation and, notably these corresponded with differences in
their propensities to adhere to cultured human ﬁbroblast and
epithelial cells. In this regard, although a relationship between LC
instability and ﬁbrillogenic potential previously has been established
[19], our experimental data suggest that decreased stability of
amyloidogenic LCs alone does not account for their cellular avidity.
Comparison of the unmodiﬁed LCs showed that there was a
concentration-dependent increase in adhesion levels observed for
Fig. 5. Fluorescence emission spectra of native and biotinylated LCs. Native (−) and biotinylated (­·­) (25 μg/ml in PBS), amyloid-associated BJPs, FRE (a, e), and IRHE (b, f), and
myeloma-associated BJPs JRHE (c, g) and HUD (d, h).
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signiﬁcant difference between HUD (λ1b) and the 2 AL LCs (λ3a) was
observed. JRHE is a cast-forming protein in vivo whereas there are no
reports of pathologic deposits associated with the HUD LC. The native
HUD protein exhibits signiﬁcantly more avidity for ﬁbroblast and
epithelial cells than JRHE. However, modiﬁcation of the lysine
residues on the λ3a LC JRHE increased its binding to HRECs while it
had little or no effect on the λ1b LC HUD.Lysyl modiﬁcation of the 2 AL-associated LCs did not lead to any
signiﬁcant alteration in their secondary structure, in as much as the β-
sheet conformation was maintained. While the CD spectra of both the
AL- and MM-associated BJPs were similar to those reported for other
LCs [27] and the biotinylated BJPs did not differ in their CD proﬁles,
their β-sheet content was increased relative to their native forms, as
has been observed for other proteins [10,12,25]. Additionally, charge
had no apparent effect on their capacity to bind cells in that the
Fig. 6. Circular dichroic spectra of native and biotinylated LCs. Native (−) and biotinylated
(­·­), amyloid-associated BJPs, FRE (a) and IRHE (b); and myeloma-associated BJPs, JRHE
(c) and HUD (d).
Table 2
Pairwise identity of aligned LC sequences.
FRE IRHE JRHE HUD
FRE ** 90 88 79
IRHE 90 ** 88 78
JRHE 88 88 ** 76
HUD 79 78 76 **
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capacity to bind cells or form amyloid in vivo. The Trp emission spectra
of the 4 BJPs after biotinylation showed a decrease in ﬂuorescence
intensity, which may reﬂect a conformational change in the microen-
vironment around one or more of the 4 Trp residues found in all LCs[28]. This effect also has been shown in the case of human serum
albumin, where a subtly altered structure and change in function has
been observed [29,30]. Based on our data, we hypothesize that lysine
modiﬁcation led to conformational changes in the amyloidogenic LCs
that exposed a binding site not accessible on the native proteins. In this
regard, it has been shown that partial denaturation of LCs increased
their binding to the heat shock protein BiP via speciﬁc peptide
sequences [31]. A number of these sequences are located close to or
include Trp 35 and are buried within the core of the LC domain
including one high afﬁnity peptide [31]. The Trp 35 within IRHE, FRE
and JRHE has a Lys residue that is 4 amino acids distant from it;
however, HUD has a Lys that is 10 amino acids removed. Therefore, a
conformational change induced by lysine modiﬁcation in the vicinity of
this Trp may effect the 3 λ3a LCs similarly, i.e. resulting in increased
adhesion to epithelial cells, but not the λ1b LC HUD. Modiﬁcation of
IgG lysyl residues also has been found to signiﬁcantly impair antigen
recognition, presumably as a result of altered conformation [32].
Further, reduced immune function in patients with diabetes has been
attributed to lack of antigen recognition induced by adduction of
glucose to lysine residues on IgG variable regions [33].
Although it is possible that the observed LC adherence to human
cells was caused by reduction in overall surface charge density, we
postulate that side chain modiﬁcations (such as those involving
lysine) led to subtle conformational changes that exposed a peptide
sequence(s) reactive with cell surface receptors. A number of such
receptors for human LCs have been identiﬁed in the kidney and
include Tamm–Horsfall protein, as well as the glycoproteins cubilin
andmegalin [34,35]. Further, AL LCs have been shown to adhere to an,
as yet, unidentiﬁed receptor onmesangial cells [36] and a relationship
between the receptor for advanced glycation end products (RAGE)
and amyloid deposition has been noted [37–41]. Our study, which
shows that modiﬁcation of λ3a LCs by biotinylation of lysyl residues
augments their binding to cultured cells, suggests that this interaction
is receptor-mediated and may occur in vivo. We posit that post-
translational alteration of LCs is an important physiological process
that can inﬂuence their stability and conformation, as well as cell
binding capability, resulting in ﬁbrillar or other types of pathologic
deposits such as amorphous aggregates.
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Fig. 7. Light chain sequence alignment: Gaps, identical residues, conserved substitutions, and semi-conserved substitutions are indicated by “–”, “*”, “:”, and “.”, respectively. Lysines
are highlighted in grey. Framework regions (FR) and complementarity determining regions (CDR) are also shown.
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